Core Viewpoint - FOXO Technologies Inc. has regained compliance with NYSE American listing requirements for stockholders equity, reporting stockholders equity greater than $4 million following recent transactions [1][3]. Financial Summary - As of September 30, 2024, the company had a stockholders' deficit of approximately $17.5 million [2]. - The company successfully exchanged $21 million of Senior Secured Notes into 21,000 shares of Series A Preferred Stock [3]. - An institutional investor provided an additional $1 million and exchanged approximately $2.2 million of Senior Notes into 2,464 shares of Series A Preferred Stock [3]. - The company settled certain liabilities with KR8 AI, Inc. in exchange for 3,000 shares of Series D Preferred Stock [3]. - Approximately $1 million of other liabilities and notes were converted into approximately 2 million shares of Class A Common Stock since October 1, 2024 [3]. Company Actions - The company filed a Current Report on Form 8-K with the SEC on December 10, 2024, detailing the transactions and related actions [4]. - The CEO expressed optimism about the company's future growth and commitment to shareholder benefits [3]. Company Overview - FOXO Technologies Inc. operates three subsidiaries, including Foxo Labs, Inc., which focuses on biotechnology, and Myrtle Recovery Centers, Inc., a behavioral health facility [5]. - Rennova Community Health, Inc. operates a critical access hospital in East Tennessee [6].
FOXO TECHNOLOGIES INC. ANNOUNCES THAT STOCKHOLDERS EQUITY IS GREATER THAN $4M, WHICH IS REQUIRED TO MEET THE CONTINUED LISTING REQUIREMENTS OF THE NYSE AMERICAN EXCHANGE